美股A股
StockGist
Back
8-K2026-03-05· grok-4-1-fast-non-reasoning

CELUW · Celularity Inc.

0001493152-26-009017

SEC filing

Summary

On February 27, 2026, Joseph DosSantos, SVP, Finance and Acting Chief Financial Officer of Celularity Inc., left the Company for personal reasons. The Company appointed John Sprague as Acting Chief Financial Officer on the same date.

Key takeaways